PD L1 News and Research

RSS
European Commission Approves Erdafitinib for Advanced Urothelial Carcinoma

European Commission Approves Erdafitinib for Advanced Urothelial Carcinoma

Unveiling IRF1's Influence on Cancer Progression and Treatment Using Histology and Flow Cytometry

Unveiling IRF1's Influence on Cancer Progression and Treatment Using Histology and Flow Cytometry

Immune Checkpoint Inhibitors Confer a Protective Effect on Bone by Promoting Osteogenesis

Immune Checkpoint Inhibitors Confer a Protective Effect on Bone by Promoting Osteogenesis

AI-Powered Drug Breakthrough: Insilico Unveils Potent FGFR2/3 Inhibitor for Solid Tumors

AI-Powered Drug Breakthrough: Insilico Unveils Potent FGFR2/3 Inhibitor for Solid Tumors

Study Reveals an Immunological Strategy to Overcome Microbiome-Related Immunotherapy Resistance

Study Reveals an Immunological Strategy to Overcome Microbiome-Related Immunotherapy Resistance

Identifying Lung Cancer Patients Who May Not Respond Well to Immunotherapy by MYC Gene Activation

Identifying Lung Cancer Patients Who May Not Respond Well to Immunotherapy by MYC Gene Activation

Additional therapeutic maneuver may be needed to stop some metastasized tumors                                               Cancer That...

Additional therapeutic maneuver may be needed to stop some metastasized tumors Cancer That...

Keeping lymph nodes in the body can boost the efficacy of cancer immunotherapy

Keeping lymph nodes in the body can boost the efficacy of cancer immunotherapy

Iron-dependent cell death can be used to improve immunotherapies against liver cancer

Iron-dependent cell death can be used to improve immunotherapies against liver cancer

Strata Oncology publishes study validating integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

Strata Oncology publishes study validating integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

AI-based strategy helps discover high-affinity antibody drugs

AI-based strategy helps discover high-affinity antibody drugs

Researchers report the identification of novel small molecules that stimulate human adaptive immune responses

Researchers report the identification of novel small molecules that stimulate human adaptive immune responses

Giving attention to beta cells instead of the immune system could be a chance to prevent type 1 diabetes

Giving attention to beta cells instead of the immune system could be a chance to prevent type 1 diabetes

Lipid nanoparticles successfully stopped the emergence and development of tumors cells, a new study reveals

Lipid nanoparticles successfully stopped the emergence and development of tumors cells, a new study reveals

Vitamin E can reinvigorate dendritic cells to enhance immunotherapy responses

Vitamin E can reinvigorate dendritic cells to enhance immunotherapy responses

Spatial maps offer insights into the battle between melanoma cells and immune cells

Spatial maps offer insights into the battle between melanoma cells and immune cells

Single-cell spatial analysis may provide information about neoadjuvant therapy for triple-negative breast cancer

Single-cell spatial analysis may provide information about neoadjuvant therapy for triple-negative breast cancer

New strategy to improve the therapeutic efficacy of liver cancer immunotherapy

New strategy to improve the therapeutic efficacy of liver cancer immunotherapy

New model for early prediction of cancer patients' response to immunotherapy

New model for early prediction of cancer patients' response to immunotherapy

New technology efficiently delivers immune checkpoint inhibitors for treating brain tumors

New technology efficiently delivers immune checkpoint inhibitors for treating brain tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.